Advertisement

Topics

Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation

19:00 EST 9 Feb 2017 | Arthritis Research and Therapy

Symmetric (SDMA) and asymmetric (ADMA) dimethylarginines have emerged as novel biomarkers of cardiovascular disease (CVD) in several disease settings associated with atherosclerosis. Rheumatoid arthritis (RA) ...

Original Article: Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation

NEXT ARTICLE

More From BioPortfolio on "Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation"

Advertisement
Quick Search
Advertisement
Advertisement